Hyderabad — 29th June 2009 — GVK Biosciences (GVK BIO) today announced that it has entered into an Agreement with Dr. Kimito Funatsu, University of…
News Category: Press Release
GVK Biosciences Responds to DCGI’s Letter on Clinical Trial of Wyeth’s Investigational Vaccine
This refers to the media reports relating to the death of a child who was participating in a clinical trial of an investigational vaccine for…
GVK Biosciences and Crelux set up Fragment-Based Drug Discovery Platform to Deliver Lead Molecules
Munich, Germany; Hyderabad, India — January 29, 2009 — GVK Biosciences (GVK BIO) and CRELUX announced today that they have set-up a highly robust fragment-based…
Harvard Professor Tarun Khanna to Join GVK BIO Board
Hyderabad, India — July 22, 2008 — GVK Biosciences (GVK BIO), Asia’s leading Contract Research Organization, today announced the appointment of Prof. Tarun Khanna to…
GVK BIO Enters Into Drug Discovery Pact with Wyeth Pharmaceuticals
Hyderabad, India — May 26, 2008 — GVK BIO today announced that it has entered into a research agreement with Wyeth Pharmaceuticals, a division of…
GVK Biosciences Licenses its Toxicity Database to AstraZeneca
Hyderabad, India — February 18, 2008 — GVK Biosciences (GVK BIO) announced that it has licensed its Mechanism Based Toxicity Database (MBT) to AstraZeneca. MBT…
